{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:52:15Z","timestamp":1790621535649,"version":"4.1.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/mnm.0000000000000417","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T07:39:46Z","timestamp":1445499586000},"page":"188-196","source":"Crossref","is-referenced-by-count":19,"title":["64Cu-DOTA as a surrogate positron analog of Gd-DOTA for cardiac fibrosis detection with PET"],"prefix":"10.1097","volume":"37","author":[{"given":"Heejung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Davies-Venn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Yeun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengsheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang H.","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bluemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210212","first-page":"571","article-title":". Assessment of blood flow with 68Ga-DOTA PET in experimental inflammation: a validation study using 15O-water.","volume":"4","author":"Autio","year":"2014","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R2-12-20210212","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1148\/radiol.12110918","article-title":"MR myocardial perfusion imaging.","volume":"266","author":"Coelho-Filho","year":"2013","journal-title":"Radiology"},{"key":"R3-12-20210212","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/RLI.0b013e318059b58b","article-title":"Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.","volume":"42","author":"Herborn","year":"2007","journal-title":"Invest Radiol"},{"key":"R4-12-20210212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13244-014-0366-9","article-title":". T1 mapping: characterisation of myocardial interstitial space.","volume":"6","author":"Perea","year":"2015","journal-title":"Insights Imaging"},{"key":"R5-12-20210212","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00004424-199112000-00006","article-title":". Quantitation of reperfused myocardial infarction by Gd-DOTA-enhanced magnetic resonance imaging. An experimental study.","volume":"26","author":"Ovize","year":"1991","journal-title":"Invest Radiol"},{"key":"R6-12-20210212","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiovascular magnetic resonance.","volume":"57","author":"Mewton","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R7-12-20210212","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1081\/JCMR-120022267","article-title":"How we perform delayed enhancement imaging.","volume":"5","author":"Kim","year":"2003","journal-title":"J Cardiovasc Magn Reson"},{"key":"R8-12-20210212","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1007\/s12410-014-9287-8","article-title":"T1 mapping for characterization of intracellular and extracellular myocardial diseases in heart failure.","volume":"7","author":"Maestrini","year":"2014","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"R9-12-20210212","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2009.04.094","article-title":"The role of cardiovascular magnetic resonance imaging in heart failure.","volume":"54","author":"Karamitsos","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R10-12-20210212","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1524\/ract.93.4.239.64070","article-title":"Semi-remote production of 64CuCuCl2 and preparation of high specific activity 64CuCu-ATSM for PET studies.","volume":"93","author":"Szajek","year":"2005","journal-title":"Radiochimica Acta"},{"key":"R11-12-20210212","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00259-011-2052-1","article-title":". PET imaging of angiogenesis after myocardial infarctionreperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.","volume":"39","author":"Gao","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-12-20210212","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2967\/jnumed.110.080606","article-title":". 18F-FPPRGD2 and 18F-FDG PET of response to Abraxane therapy.","volume":"52","author":"Sun","year":"2011","journal-title":"J Nucl Med"},{"key":"R13-12-20210212","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1148\/radiology.166.3.3340763","article-title":". Gd-DOTA: characterization of a new paramagnetic complex.","volume":"166","author":"Bousquet","year":"1988","journal-title":"Radiology"},{"key":"R14-12-20210212","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehr481","article-title":". Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.","volume":"33","author":"Ugander","year":"2012","journal-title":"Eur Heart J"},{"key":"R15-12-20210212","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications.","volume":"99","author":"Caravan","year":"1999","journal-title":"Chem Rev"},{"key":"R17-12-20210212","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1532-429X-14-64","article-title":". Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience.","volume":"14","author":"Kellman","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"key":"R18-12-20210212","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1148\/radiol.13131280","article-title":". Quantification of myocardial extracellular volume fraction with cardiac MR imaging for early detection of left ventricle involvement in systemic sclerosis.","volume":"271","author":"Thuny","year":"2014","journal-title":"Radiology"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000000417","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:33:36Z","timestamp":1620963216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201602000-00012"}},"subtitle":["pharmacokinetic study in a rat model of chronic MI"],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000000417","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}